Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention.

Autor:	Zeremski M; Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY (MZ, AHT); START Treatment & Recovery Centers, Brooklyn, NY (RZ, SK, CS, LSB, AHT); Department of Biostatistics, University at Buffalo, State University of New York, Buffalo, NY (RBD, YC); and Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY (RBD, AHT)., Zavala R, Dimova RB, Chen Y, Kritz S, Sylvester C, Brown LS Jr, Talal AH
Jazyk:	angličtina
Zdroj:	Journal of addiction medicine [J Addict Med] 2016 Mar-Apr; Vol. 10 (2), pp. 104-9.
DOI:	10.1097/ADM.0000000000000196
Abstrakt:	Objectives: Lack of knowledge about hepatitis C virus (HCV) is a principal barrier to substance users' engagement into care for the infection. As a step toward their increased engagement into HCV care, the objective of this study was to deliver an HCV-related educational intervention to substance users on opioid agonist therapy and to assess the change in HCV-related knowledge after the intervention. Methods: We designed a comprehensive and interactive hepatitis C-related educational intervention, composed of two 30 to 60-minute sessions conducted during 2 consecutive weeks. Patients' knowledge about hepatitis C was assessed immediately before and after the intervention using a 7-item questionnaire. Results: A total of 110 patients completed both educational sessions. Patients' mean age was 54.7 ± 7.8 years, 58.7% were men, 70.4% African American, and 30% were Hispanic. We observed a significant increase in HCV-related knowledge after completion of the educational intervention. Whereas 65.45% of patients answered 5 or more questions correctly before the intervention, 83.64% had 5 or more questions answered correctly on the posteducational quiz (P < 0.001). Male sex, ever receiving an HCV diagnostic test before the educational intervention, and a higher level of HCV knowledge on the preeducational quiz were found to be significantly associated with HCV-related knowledge after the educational intervention. Conclusions: Patients' knowledge about hepatitis C was found to be significantly improved after the educational intervention. Therefore, HCV-related education could be the first step toward effective enrollment of patients on opioid agonist therapy into hepatitis C care.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu